The World Health Organization has approved a version of a widely used cholera vaccine that could help address a surge in cases that has depleted the global vaccine stockpile and left poorer countries scrambling to contain epidemics.
WHO authorized the vaccine, made by EuBiologics, which also makes the formulation now used, last week. The new version, called Euvichol-S, is a simplified formula that uses fewer ingredients, is cheaper, and can be made more quickly than the old version.
The vaccine was shown to be help preventing the diarrheal disease in late stage research conducted in Nepal.
WHO’s approval means donor agencies like the vaccines alliance Gavi and UNICEF can now buy it for poorer countries. Leila Pakkala, director of UNICEF’s supply division, said in a statement that the agency will be able to boost supplies by more than 25%.
Protesting Spanish professor 'warned university' over Confucius Institutes — Radio Free Asia
Commentary: Why Washington's rage over China's Micron ban is calling white black
Lisa Blatt nears a record 50 arguments before the Supreme Court
Middle East welcomes China's role as peace builder, rejects US determinism
Police detective lays bare Hells Angels' twisted links to the MAFIA
Putting people first: the guiding light in China's COVID fight
Decreased clout reason for U.S. anger at Beijing
Bengals likely to look for an offensive tackle and run
Senior Chinese leaders attend deliberations at annual legislative session
EU proposes youth mobility agreement with UK to help youngsters travel, work and live in both areas
Commentary: China's COVID policy optimization to propel global economic growth